Modified neck dissection in the treatment of differentiated thyroid carcinoma

Elena Orsenigo, Edoardo Beretta, Gilberto Mari, Paola Gini, Alessandra Baldi, Paolo Veronesi, Andrea Vignali, Gigliola Calori, Valerio Di Carlo

Research output: Contribution to journalArticlepeer-review


The prognosis of differentiated carcinoma of the thyroid has been reported to be extremely favourable. Previous studies have concluded that lymph node metastasis do not affect survival rates in patients with differentiated thyroid carcinoma. Therefore, nodal metastasis has not been evaluated as a prognostic factor in recent definitions of risk groups. To determine the significance of nodal disease, we reviewed 219 consecutive patients with differentiated thyroid cancer (191 papillary, 14 follicular and 14 Hurtle cell carcinomas). Fifty-five patients were treated with modified neck dissection and all of them received adjuvant radioiodine. There were recurrences in 25 patients (11.4%), with follow-up ranging from 6 months to 14 years. Systemic disease occurred synchronously in two patients, and four patients died of thyroid carcinoma.

Original languageEnglish
Pages (from-to)286-288
Number of pages3
JournalEuropean Journal of Surgical Oncology
Issue number4
Publication statusPublished - 1997


  • Modified neck dissection
  • Recurrence
  • Surgery
  • Thyroid cancer

ASJC Scopus subject areas

  • Oncology
  • Surgery


Dive into the research topics of 'Modified neck dissection in the treatment of differentiated thyroid carcinoma'. Together they form a unique fingerprint.

Cite this